Companies recognize that their success with digital starts with accurate customer data, but many struggle to manage the overwhelming volume of different data types from hundreds of sources.
Here’s how pharma businesses can speed the handling of adverse events, reduce costs, improve patient safety and spur growth through pharmacovigilance automation.
Lofaso discusses strategies that biotech companies can take once its time to make the big push.
The era of big pharma as product-first companies must end, as services become the larger priority.
Pharma companies are struggling to maintain a high level of cybersecurity amidst the pandemic.
If you wish for your team to be diligent, innovative, and collaborative, you must first exhibit these traits yourself
Pharma companies may benefit from meeting challenges and embracing small molecule drug discovery.
Conferences, congresses, and the digital discussions kicked off by those events create a halo effect that amplifies scientific information more so than other scientific activities.
How life sciences companies can design an effective operating model for DOL engagements.
Utilizing natural language processing technologies to improve search capabilities and advance the development of therapies.
How pharma medical affairs and commercial teams are synchronizing their capabilities to boost omnichannel marketing strategies and better understand customer engagement needs.
The top changes necessary in planning and designing pharma market access plans, including a revamp of the payer-value equation at pivotal points in the product life cycle.
This white paper describes how digitizing medicines can drive patient engagement, reduce non-adherence, and enhance supply chain visibility.
Pharma companies should review their commission-based compensation arrangements with independent contractors to address enforcement risk under the Anti-Kickback Statute, in light of recent Department of Justice enforcement.
Brand positioning that targets HCPs is often irrelevant to the payer mindset. Fortunately, market access teams have an option, writes Ed Shankman.
Measuring the relationship between a product’s reimbursement position and performance begins with gathering key data points for as many products as possible.
In today’s fragmented commercial environment, navigating a more complex set of challenges while adapting new approaches to product launch is critical for biopharma brand teams.
Overcoming persistent barriers to health equity in oncology trials will require innovation and cooperation.
With AI/ML and cognitive technologies set to become a key enabler of the pharma commercialization process, Srini Rajamani outlines how pharma companies can leverage tech effectively.
Looking to hold an advisory board? Here are a few suggestions.
The industry has struggled to recruit talent for years, and the challenge is only getting more difficult. Pharma companies need to recruit differently.
Learn how breakthrough patient experience strategies can help achieve your study goals in this upcoming webcast. Lead by renowned neuroscientist and behavioral economist Dr. Paul Glimcher, it’s the one webcast this year your team can’t afford to miss. Live: Tuesday, May 19, 2020 at 1pm EDT | 12pm CDT | 10am PDT On demand available after airing until May 19, 2021.
Recent increases in employee burnout and turnover must be addressed.